The Application of Nasopharyngeal Airway Combined With Nasal High-flow Oxygen Therapy During Painless Gastroscopy in Patients With Obesity

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Gastroscopy is a commonly used, direct, and reliable method for screening and diagnosing digestive tract diseases. However, as an invasive examination, it can cause adverse reactions such as pain, nausea, vomiting, and choking cough in patients. Compared with ordinary gastroscopy, painless gastroscopy offers higher comfort and satisfaction for patients and greater convenience for endoscopists during operation. The most common complication of painless gastroscopy diagnosis and treatment is hypoxia. High-flow nasal cannulala (HFNC) provides a higher oxygen concentration and flow rate than an ordinary nasal catheter. It has the functions of heating and humidifying, which can relieve the pressure on the nasal mucosa cilia, keep the airway unobstructed and moist, and reduce the risk of epistaxis. Due to changes in airway anatomical structures such as fat accumulation in the head and neck and hyperplasia of oropharyngeal soft tissues, obese patients are more prone to hypoxia during gastroscopy under sedation. Therefore, HFNC is often used to reduce the occurrence of hypoxia. The nasopharyngeal airway (NPA) is used to maintain the patency of the upper respiratory tract and is suitable for patients with spontaneous breathing but partial obstruction of the upper respiratory tract. It is worth exploring how effective the combination of HFNC and NPA is in improving hypoxemia in obese patients during sedation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients undergoing painless gastroscopy;

• Patients with an age greater than 18 years old;

• American Society of Anesthesiologists (ASA) physical status classification from Grade I to Grade III;

• Body Mass Index (BMI) greater than 28 kg/m²

Locations
Other Locations
China
Nanjing First Hospital
RECRUITING
Nanjing
Contact Information
Primary
Jing Hu, Master
hujingmz@163.com
15366110201
Backup
Tao Shan, Master
858727933@qq.com
18852095135
Time Frame
Start Date: 2025-05-14
Estimated Completion Date: 2026-05-31
Participants
Target number of participants: 364
Treatments
No_intervention: HFNC30L/min
The patient receives pre-oxygenation with pure oxygen at 30 L/min for 1 minute. After sedation, when the patient's breathing becomes slightly slower but stable and the eyelash reflex disappears, continue to supply oxygen at a flow rate of 30 L/min
Experimental: HFNC30L/min AND NPA
The patient receives pre-oxygenation with pure oxygen at 30 L/min for 1 minute. After sedation, the nasopharyngeal airway (NPA) is inserted when the patient's breathing becomes slightly slow but stable and the eyelash reflex disappears
Sponsors
Leads: Nanjing First Hospital, Nanjing Medical University

This content was sourced from clinicaltrials.gov